$Cartesian Therapeutics (RNAC.US)$ FMR had a top position in...
$Cartesian Therapeutics(RNAC.US$ FMR had a top position in Viking Therapeutics, and here in Cartesian as well. The reverse split is to allow more institutions to follow suit. If you were to read the paper closely on the pipeline, their RNA cell therapy extends to a suite of autoimmune diseases. With a production up and coming, more partnership might be announced very soon.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
